Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. tumor localization
Show results for
Products
Services
Software
Applications

Companies

News
Articles

Refine by
Date

  • Older

Tumor Localization Articles & Analysis

12 news found

Beyond Cancer Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases

Beyond Cancer Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases

The data were published in an article entitled, “Gaseous Nitric Oxide Tumor Ablation Induces an Anti-Tumor Abscopal Effect,” in the peer-reviewed journal Cancer Cell International (“CCI”). ...

ByBeyond Air Inc


An Overview of Glioblastoma

An Overview of Glioblastoma

It is estimated that more than 240,000 cases of brain and nervous system tumors are diagnosed each year around the world. The most common and most lethal of these cancerous tumors are glioblastoma (GBM). ...

ByDiverse Biotech Inc


Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS

Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS

Afami-cel SPEAR T-cells target MAGE-A4+ tumors. MAGE-A4 is highly expressed in synovial sarcoma and MRCLS in the context of HLA-A*02. ...

ByAdaptimmune LLC


Camurus announces dosing initiated in Phase 3 study of CAM2029 in patients with neuroendocrine tumors

Camurus announces dosing initiated in Phase 3 study of CAM2029 in patients with neuroendocrine tumors

Camurus (NASDAQ STO: CAMX) today announces that dosing has been initiated in the company’s randomized, active-controlled Phase 3 study, SORENTO, which aims to evaluate the efficacy and safety of octreotide subcutaneous depot (CAM2029) in the treatment of patients with neuroendocrine tumors localized in the gastrointestinal tract or pancreas (GEP-NET). ...

ByCamurus AB


PsiOxus Therapeutics updates agreement with Bristol-Myers Squibb to advance their clinical stage immuno-oncology collaboration

PsiOxus Therapeutics updates agreement with Bristol-Myers Squibb to advance their clinical stage immuno-oncology collaboration

Our portfolio comprises differentiated products that are all delivered systemically but act locally within the tumor. At PsiOxus we are advancing our pipeline of clinical and preclinical stage candidates and establishing strategic partnerships with immuno-oncology leaders to bring these tumor re-engineering products to patients. About ...

ByPsiOxus Therapeutics Ltd.


University Hospitals Is First in Cleveland To Offer GT Medical Technologies` New Targeted Therapy for Brain Tumors

University Hospitals Is First in Cleveland To Offer GT Medical Technologies` New Targeted Therapy for Brain Tumors

Sloan, the Director of the Brain Tumor Program. Over 400,000 patients are living with a brain tumor in the U.S. each year. The previous standard of care for patients with operable brain tumors is the surgical removal of the tumor followed by adjuvant therapy, including radiation and chemotherapy. ...

ByGT Medical Technologies, Inc.


University Hospitals Is First in Cleveland To Offer GT Medical Technologies` New Targeted Therapy for Brain Tumors

University Hospitals Is First in Cleveland To Offer GT Medical Technologies` New Targeted Therapy for Brain Tumors

Sloan, the Director of the Brain Tumor Program. Over 400,000 patients are living with a brain tumor in the U.S. each year. The previous standard of care for patients with operable brain tumors is the surgical removal of the tumor followed by adjuvant therapy, including radiation and chemotherapy. ...

ByGT Medical Technologies, Inc.


GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors

GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors

This registry will shed further light on the real-world benefits of STaRT for people with brain tumors." The multicenter observational study will enroll 600 patients with brain tumors of any pathology who have received treatment with GammaTile Therapy. ...

ByGT Medical Technologies, Inc.


Dilon Technologies® Inc. acquires the DuneMedical’s MarginProbe®

Dilon Technologies® Inc. acquires the DuneMedical’s MarginProbe®

” As a global provider of breast cancer solutions, Dilon’s Navigator® Gamma Probes are used for radio-guided lymphatic mapping and tumor localization world-wide. “The combination of Dilon’s class leading Navigator® Gamma Probes with the MarginProbe® is a natural fit. ...

ByDilon Technologies Inc.


VeraForm® Proving Itself Across Multiple Imaging Platforms

VeraForm® Proving Itself Across Multiple Imaging Platforms

The MOZART® System from KUBTEC Medical Imaging stands alone as it identifies the exact location of three dimensional objects such as tumors and localization devices inside breast cancer specimens. The VeraForm adaptable tissue marker is a radiopaque, continuous, 3-D marker that is highly visible in imaging such as Mozart and beautifully demonstrates the ...

ByVidera Surgical Inc.


Clips. First We Pleaded for Them. Now, Not So Much: A Radiation Oncologist’s Perspective

Clips. First We Pleaded for Them. Now, Not So Much: A Radiation Oncologist’s Perspective

It’s almost impossible to accurately remove a 3D tumor using limited 2D information from a few points. Now imagine if someone didn’t leave a localization wire for you to follow but instead was kind enough to spiral or wind a filament around the outside edges of the entire tumor. ...

ByVidera Surgical Inc.


Director of Breast Surgery at NAPBC Accredited Facility Realizes Clinical Value of MarginProbe® in Very First Case

Director of Breast Surgery at NAPBC Accredited Facility Realizes Clinical Value of MarginProbe® in Very First Case

For example, transitioning to a wireless tumor localization approach improves the comfort of his patients by avoiding the painful and cumbersome wire. ...

ByDilon Technologies Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT